Alternative Excipients for Protein Stabilization in Protein Therapeutics: Overcoming the Limitations of Polysorbates
A. Ruiz(University of Bonn), Alf Lamprecht(University of Bonn), Maryam A. Shetab Boushehri(University of Bonn), Julia Buske(Boehringer Ingelheim (Germany)), Stefan Carle(Boehringer Ingelheim (Germany)), Patrick Garidel(Boehringer Ingelheim (Germany)), Tamara Phan(Universität Ulm)
Cited by 93
Related Papers
A comprehensive screening platform for aerosolizable protein formulations for intranasal and pulmonary drug delivery
|International Journal of Pharmaceutics|2017|55
An in-depth examination of fatty acid solubility limits in biotherapeutic protein formulations containing polysorbate 20 and polysorbate 80
|International Journal of Pharmaceutics|2020|47
The Hsp90 machinery facilitates the transport of diphtheria toxin into human cells
|Scientific Reports|2017|42
Assessing the polysorbate degradation fingerprints and kinetics of lipases – how the activity of polysorbate degrading hydrolases is influenced by the assay and assay conditions
|European Journal of Pharmaceutical Sciences|2021|37
Nose-to-Brain delivery of insulin for Alzheimer’s disease
|ADMET & DMPK|2015|35